Meanwhile, in the C3A human liver cancer cells, MCF-7 breast cancer cells and CFPAC-1 pancreatic cancer cells treated by MR-409, there was also a dramatic decrease in phosphorylation of GHR/JAK2/STAT5 (Figure 8B-8D). This evidence concerns the gene JAK2 and breast cancer.